Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
Details for Australian Patent Application No. 2003243101 (hide)
International Classifications
Event Publications
11 September 2003 Complete Application Filed
Priority application(s): 0202287-9 19.07.02 SE; 60/426,240 14.11.02 US
18 March 2004 Application Open to Public Inspection
Published as AU-B-2003243101
10 January 2008 Alteration of Name
The name of the applicant has been altered to Biovitrum AB (publ)
13 May 2010 Application Accepted
Published as AU-B-2003243101
9 September 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003243102-Methods for identifying glucose uptake modulators
2003243100-ARRANGEMENTS FOR HOUSING RESTING ANIMALS AND DEVICES FOR PARTITIONING SUCH ARRANGEMENTS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser